Neo-Mycodermol (Ciclopirox Olamine)

Ciclopirox olamine interferes with fungal cell metabolism by blocking the transport of essential nutrients and metal ions into the cell. This disruption impairs membrane function and enzyme activity, ultimately inhibiting fungal growth and leading to the gradual clearance of the infection from the skin.

The specific dosing regimen for Neo-Mycodermol is determined by the prescribing healthcare professional based on the infection type, severity, patient age and skin condition. Typically, a thin layer is applied to the cleaned skin once or twice daily for the period recommended by the prescriber.

Safety data for ciclopirox olamine in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Neo-Mycodermol.

To place an order, submit an enquiry on the Neo-Mycodermol product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Compared with azole‑based creams, ciclopirox olamine offers a broader spectrum of activity against dermatophytes, yeasts and some resistant strains. It also has a different mechanism of action, which can be advantageous when resistance to azoles is a concern. However, clinical choice depends on infection type, patient tolerance and prescriber preference.

Neo-Mycodermol should be stored at room temperature, ideally below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed when not in use to maintain stability.

Before application, wash and gently dry the affected skin area. Apply a thin, even layer of Neo-Mycodermol to the lesion and a small margin of surrounding skin. Follow the frequency and duration prescribed by the healthcare professional, usually once or twice daily, and avoid covering the area with occlusive dressings unless directed.

The most serious adverse reactions include severe allergic responses such as angioedema, extensive contact dermatitis, and rare cases of skin ulceration. If any signs of a serious reaction—such as swelling, blistering, or difficulty breathing—appear, discontinue use immediately and seek medical attention.

Neo-Mycodermol should not be used by individuals with a known hypersensitivity to ciclopirox olamine or any excipients in the formulation. It is also contraindicated on broken or ulcerated skin, and caution is advised for children under the age specified by the prescriber or local regulatory guidelines.